论文部分内容阅读
目的:评价糖尿病微血管并发症患者高HCY血症应用甲钴胺、叶酸药物临床效果。方法:对80例高同型半胱氨酸(HCY)血症(其中单纯高同型半胱氨酸血症20例,2型糖尿病无并发症组30例,合并微血管并发症组30例均口服甲钴胺片、叶酸片后1个月复查血浆HCY。结果:正常对照组全组降至正常,糖尿病无微血管病变组血浆HCY下降幅度与糖尿病微血管病变组血浆HCY下降幅度无显著差异。结论口服甲钴胺片、叶酸片等药物,是治疗高同型半胱氨酸(HCY)血症的一种方法。
Objective: To evaluate the clinical efficacy of mecobalamin and folic acid in patients with hypercapnic hyperlipidemia of diabetic microvascular complications. Methods: Eighty patients with homocysteine (HCY), including 20 cases with hyperhomocysteinemia, 30 cases with type 2 diabetes without complications and 30 cases with microvascular complications Coban amine tablets, folic acid tablets were reviewed one month after the plasma HCY.Results: The normal control group fell to normal in all groups, diabetic patients without microvascular lesions HCY decline and plasma microvascular lesions in patients with no significant difference.Conclusion Oral armor Cobalt amine tablets, folic acid tablets and other drugs, is a method of treatment of homocysteine (HCY) hyperlipidemia.